PSMB9 codon 60 polymorphisms have no impact on the activity of the immunoproteasome catalytic subunit B1i expressed in multiple types of solid cancer.

MLA

Ji Eun Park, et al. “PSMB9 Codon 60 Polymorphisms Have No Impact on the Activity of the Immunoproteasome Catalytic Subunit B1i Expressed in Multiple Types of Solid Cancer.” PLoS ONE, vol. 8, no. 9, Jan. 2013, p. e73732. EBSCOhost, https://doi.org/10.1371/journal.pone.0073732.

APA

Ji Eun Park, Lin Ao, Zachary Miller, Kyungbo Kim, Ying Wu, Eun Ryoung Jang, Eun Young Lee, Kyung Bo Kim, & Wooin Lee. (2013). PSMB9 codon 60 polymorphisms have no impact on the activity of the immunoproteasome catalytic subunit B1i expressed in multiple types of solid cancer. PLoS ONE, 8(9), e73732. https://doi.org/10.1371/journal.pone.0073732

Chicago

Ji Eun Park, Lin Ao, Zachary Miller, Kyungbo Kim, Ying Wu, Eun Ryoung Jang, Eun Young Lee, Kyung Bo Kim, and Wooin Lee. 2013. “PSMB9 Codon 60 Polymorphisms Have No Impact on the Activity of the Immunoproteasome Catalytic Subunit B1i Expressed in Multiple Types of Solid Cancer.” PLoS ONE 8 (9): e73732. doi:10.1371/journal.pone.0073732.